Although the depletion of miRNA or target genes both resulted in energy metabolic disorders, whether these metabolic phenotypes under antagomiR treatment were caused by increased expression of SLC2A1 and GLIS2 remains unclear. This evidence concerns the gene GLIS2 and Disorder of energy metabolism.